Metabolically healthy obesity and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies

Obesity Reviews

Volumn 15, Issue 6, 2014, Pages 504-515

  Bell, J A ^a   Kivimaki, M ^a   Hamer, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Metabolic health; Obesity; Type 2 diabetes

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; C REACTIVE PROTEIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LONGITUDINAL STUDY; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROSPECTIVE STUDY; RISK FACTOR; SYSTEMATIC REVIEW; AGING; ANALYSIS; BLOOD; BODY MASS; COMPLICATION; DIABETES MELLITUS, TYPE 2; FEMALE; MALE; MEDLINE; METABOLISM; RISK;

AGING; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MEDLINE; OBESITY; PROSPECTIVE STUDIES; RISK; RISK FACTORS; TRIGLYCERIDES;

EID: 84899637656     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12157     Document Type: Article

References (55)

1. International Diabetes Federation. IDF Diabetes Atlas. 2012.
2. Vazquez G, Duval S, Jacobs DR, Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 2007; 29: 115-128.
3. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846.
4. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
5. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107.
6. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 2000; 23: 465-471.
7. Malik VS, Popkin BM, Bray GA, Després J-P, Hu FB. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010; 121: 1356-1364.
8. Malik VS, Popkin BM, Bray GA, Després J-P, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010; 33: 2477-2483.
9. Schulze MB, Manson JE, Ludwig DS etal. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004; 292: 927-934.
10. Hu FB, Li TY, Colditz GA, Willett WC, Manson JE. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003; 289: 1785-1791.
11. Hu FB, Manson JE, Stampfer MJ etal. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345: 790-797.
12. Abate N, Chandalia M. The impact of ethnicity on type 2 diabetes. J Diabetes Complications 2003; 17: 39-58.
13. Lee JWR, Brancati FL, Yeh H-C. Trends in the prevalence of type 2 diabetes in Asians versus whites results from the United States National Health Interview Survey, 1997-2008. Diabetes Care 2011; 34: 353-357.
14. Wildman RP, Muntner P, Reynolds K etal. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering - prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168: 1617-1624.
15. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005; 13: 1116-1122.
16. Primeau V, Coderre L, Karelis AD etal. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971-981.
17. Wildman RP. Healthy obesity. Curr Opin Clin Nutr Metab Care 2009; 12: 438-443.
18. Ortega FB, Lee DC, Katzmarzyk PT etal. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013; 34: 389-397.
19. Finucane MM, Stevens GA, Cowan MJ etal. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377: 557-567.
20. Stroup DF, Berlin JA, Morton SC etal. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
21. Steptoe A, Breeze E, Banks J, Nazroo J. Cohort profile: the English longitudinal study of ageing. Int J Epidemiol 2013; 42: 1640-1648.
22. Hamer M, Batty GD, Kivimaki M. Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing. Mol Psychiatry 2012; 17: 940-945.
23. Pierce M, Zaninotto P, Steel N, Mindell J. Undiagnosed diabetes - data from the English longitudinal study of ageing. Diabet Med 2009; 26: 679-685.
24. Williams E, Tapp R, Magliano D, Shaw J, Zimmet P, Oldenburg B. Health behaviours, socioeconomic status and diabetes incidence: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Diabetologia 2010; 53: 2538-2545.
25. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes. JAMA 2007; 298: 2654-2664.
26. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk of type 2 diabetes a meta-analysis of prospective observational studies. Diabetes Care 2005; 28: 719-725.
27. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069-1078.
28. Riley RD, Higgins J, Deeks JJ. Interpretation of random effects meta-analyses. BMJ 2011; 342: d549.
29. Appleton SL, Seaborn CJ, Visvanathan R etal. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype a cohort study. Diabetes Care 2013; 36: 2388-2394.
30. Hadaegh F, Bozorgmanesh M, Safarkhani M, Khalili D, Azizi F. Predictability of body mass index for diabetes: affected by the presence of metabolic syndrome? BMC Public Health 2011; 11: 1-9.
31. Magnussen CG, Koskinen J, Chen W etal. Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. Circulation 2010; 122: 1604-1611.
32. Aguayo A, Vela A, Aniel-Quiroga A etal. Absence of diabetes mellitus type 2 in obese children and adolescents in the north of Spain. J Pediatr Endocrinol Metab 2013; 26: 25-29.
33. Arnlov J, Sundstrom J, Ingelsson E, Lind L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care 2011; 34: 61-65.
34. Hwang L-C, Bai C-H, Sun C-A, Chen C-J. Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac J Clin Nutr 2012; 21: 227-233.
35. Kim C-H, Kim H-K, Bae S-J, Kim E-H, Park J-Y. Independent impact of body mass index and metabolic syndrome on the risk of type 2 diabetes in Koreans. Metab Syndr Relat Disord 2012; 10: 321-325.
36. Meigs JB, Wilson PWF, Fox CS etal. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906-2912.
37. Soriguer F, Gutiérrez-Repiso C, Rubio-Martín E etal. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab 2013; 98: 2318-2325.
38. Pajunen P, Kotronen A, Korpi-Hyovalti E etal. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D survey. BMC Public Health 2011; 11: 754.
39. Thompson SG, Higgins J. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-1573.
40. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011; 378: 169-181.
41. Stafford M, Brunner EJ, Head J, Ross NA. Deprivation and the development of obesity: a multilevel, longitudinal study in England. Am J Prev Med 2010; 39: 130-139.
42. Ludwig J, Sanbonmatsu L, Gennetian L etal. Neighborhoods, obesity, and diabetes - a randomized social experiment. N Engl J Med 2011; 365: 1509-1519.
43. Auchincloss AH, Diez Roux AV, Mujahid MS, Shen M, Bertoni AG, Carnethon MR. Neighborhood resources for physical activity and healthy foods and incidence of type 2 diabetes mellitus: the multi-ethnic study of atherosclerosis. Arch Intern Med 2009; 169: 1698-1704.
44. Diez Roux AV, Mair C. Neighborhoods and health. Ann N Y Acad Sci 2010; 1186: 125-145.
45. Stafford M, Cummins S, Ellaway A, Sacker A, Wiggins RD, Macintyre S. Pathways to obesity: identifying local, modifiable determinants of physical activity and diet. Soc Sci Med 2007; 65: 1882-1897.
46. Burdette AM, Hill TD. An examination of processes linking perceived neighborhood disorder and obesity. Soc Sci Med 2008; 67: 38-46.
47. Lee D-H, Lee I-K, Song K etal. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes results from the National Health and Examination Survey 1999-2002. Diabetes Care 2006; 29: 1638-1644.
48. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 2006; 30: 1529-1534.
49. Kantartzis K, Machann J, Schick F etal. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 2011; 54: 864-868.
50. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008; 51: 1752-1754.
51. Chaput J-P, Arguin H, Gagnon C, Tremblay A. Increase in depression symptoms with weight loss: association with glucose homeostasis and thyroid function. Appl Physiol Nutr Metab 2007; 33: 86-92.
52. Koster A, Stenholm S, Alley DE etal. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 2010; 18: 2354-2361.
53. Klöting N, Fasshauer M, Dietrich A etal. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010; 299: E506-E515.
54. Arsenault BJ, Côté M, Cartier A etal. Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese postmenopausal women with elevated blood pressure. Atherosclerosis 2009; 207: 530-533.
55. Janiszewski PM, Ross R. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care 2010; 33: 1957-1959.